US Edition
Neurocrine Biosciences to Present at Upcoming Investor Conferences in March
Neurocrine Biosciences management will engage investors with forward-looking statements at the TD Cowen 46th Annual Health Care Conference in March.
- On Feb. 24, 2026 Neurocrine Biosciences, Inc. announced from San Diego that members of the management team will attend the TD Cowen 46th Annual Health Care Conference.
- Company materials said presentations may include plans, strategies and objectives linked to financial and operating targets, framing investor expectations.
- The release included boilerplate disclaimers that `Forward-looking statements speak only as of the date` and referenced risk factors in the Form 10‑K for the year ended December 31, 2025.
- Distributed via PR Newswire and ACCESS Newswire, the announcement carried the company notice to investor channels for broad reach.
- Source files contained extensive garbled text around the press release, and the garbled passages appear in multiple places, affecting readability of surrounding content.
27 Articles
27 Articles
Armanino Foods to Participate in Upcoming Investor Conferences
PLEASANTON, CA / ACCESS Newswire / February 25, 2026 / Armanino Foods of Distinction, Inc. (OTCQX:AMNF), a leading provider of pesto and specialty frozen foods for North American foodservice, retail, and industrial customers, today announced that management will participate in…
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March
NAARDEN, the Netherlands and MIAMI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with…
The Record
Teva to Present at the Upcoming Investor Conferences in March
PARSIPPANY, N.J. and TEL AVIV, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will participate in the upcoming investor conferences in March as follows:
Coverage Details
Bias Distribution
- 56% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
